Article Sidebar

PDF
Date Published: 13/03/2022
Abstract Views: 1421
Views PDF: 398
DOI: https://doi.org/10.51298/vmj.v510i2.1961
Issue
Vol. 510 No. 2 (2022)
Section
Các bài báo
How to Cite
Thị Thu Phương, N. ., & Thị Ngân, T. . (2022). ANEMIA STATUS OF CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOTIDE ANALOG THERAPY AT HAI PHONG INTERNATIONAL GENERAL HOSPITAL IN 2020. Vietnam Medical Journal, 510(2). https://doi.org/10.51298/vmj.v510i2.1961

ANEMIA STATUS OF CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOTIDE ANALOG THERAPY AT HAI PHONG INTERNATIONAL GENERAL HOSPITAL IN 2020

Nguyễn Thị Thu Phương1,2,, Trần Thị Ngân1,2
1 Haiphong University of Medicine and Pharmacy
2 Hai Phong International General Hospital

Main Article Content

Abstract

Chronic hepatitis B virus infection is a serious global health problem. Anemia is the most common complication of cirrhosis and occurs in 75% of cases. The etiology of anemia in liver disease is diverse. Therefore, we carried out this study with the aim of investigating anemia in chronic hepatitis B patients treated at Hai Phong International General Hospital in 2020. Our study shows the rate Anemia in 2026 chronic hepatitis B patients after 12 weeks of treatment was 9.1% with an average hemoglobin concentration of 119,3 ± 13,7 g/dL. The results of multivariable logistic regression analysis showed that weight, number of comorbidities and cirrhosis significantly affected the occurrence of anemia in the study group with the odds ratio (Odd ratio) respectively: 0,97, 1,25, 2,07 (p < 0,05). This result contributes to supporting clinicians in the prognostication and monitoring of hepatitis B patients to improve treatment effectiveness.

Article Details

Keywords

Chronic hepatitis B, nucleotide analogues, anemia

References

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107.
2. Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 2009; 15(37): 4653-8.
3. Mathurin SA, Aguero AP, Dascani NA, et al. [Anemia in hospitalized patients with cirrhosis: prevalence, clinical relevance and predictive factors]. Acta Gastroenterol Latinoam. 2009; 39(2): 103-11.
4. Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị một số bệnh lý huyết học. Ban hành kèm theo Quyết định số 1494/QĐ-BYT ngày 22 tháng 4 năm 2015 của Bộ trưởng Bộ Y tế. 2015:
5. Cariani E, Pelizzari AM, Rodella A, et al. Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays. J Hepatol. 2007; 46(4): 743-7.
6. Lindenbaum J, Roman MJ. Nutritional anemia in alcoholism. Am J Clin Nutr. 1980; 33(12): 2727-35.
7. Moreno Otero R, Cortes JR. [Nutrition and chronic alcohol abuse]. Nutr Hosp. 2008; 23 Suppl 2: 3-7.
8. Maruyama S, Hirayama C, Yamamoto S, et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med. 2001; 138(5): 332-7.